Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

IOC announces 45 failed tests from Beijing and London

Published 07/22/2016, 08:28 AM
© Reuters. IOC President Bach attends a news conference in Lausanne

(Reuters) - Forty-five athletes have failed dope tests after their samples from the 2008 Beijing Olympics and 2012 London Games were reanalyzed, the International Olympic Committee (IOC) said on Friday.

The results are from a second wave of retests and take the total number of athletes who tested positive for prohibited substances to 98, the IOC added in a statement.

Of the 45 failed tests announced on Friday, 30 were from Beijing, including 23 medalists, and 15 were from London. The IOC did not say if any of the London athletes had won medals.

“The new reanalysis once again shows the commitment of the IOC in the fight against doping,” IOC President Thomas Bach said.

The IOC stores samples for a decade in order to re-test using newer methods or to look for new drugs.

The results are part of the IOC's re-testing of samples from past Games to keep cheats from competing at the Rio de Janeiro Olympics in August.

The athletes are being informed, after which proceedings against them can begin. All athletes found to have infringed anti-doping rules will be banned from competing at the Rio Olympics.

The failed tests will raise further speculation about the extent of doping at the Games, just weeks before the Rio Olympics starts.

Doping scandals have plagued the build-up to the world's biggest multi-sports event with Russia potentially facing a complete Games ban following the publication of the McLaren report on Monday.

The report revealed evidence of a systematic and widespread state-sponsored doping by Russian athletes at the 2014 Sochi Winter Olympics.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The second wave of retests included 386 samples from Beijing, involving four sports and eight countries. There were 138 samples retested from London 2012, involving athletes from two sports and nine countries.

The third and fourth waves of tests are expected to continue throughout and after the Rio Games.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.